1.Safety Assessment Sweden,AstraZeneca R&D S?dert?lje,S?dert?lje,Sweden;2.Department of Biomedical Sciences and Veterinary Public Health,Division of Pathology, Pharmacology & Toxicology,Uppsala,Sweden;3.Medivir AB,Huddinge,Sweden
Abstract:
Background
This study was performed to characterize a gene-addition transgenic mouse containing a BAC (bacterial artificial chromosome) clone spanning the human CYP2C18&19 genes (tg-CYP2C18&19).